Skip to main content
SpringerLink
Log in

Cardiomyopathy

  • Chapter
Heart Disease Diagnosis and Therapy

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 881 Accesses

Abstract

Cardiomyopathies are classified as follows:

  • Hypertrophic cardiomyopathy.

  • Dilated cardiomyopathy.

  • Restrictive cardiomyopathy.

  • Arrhythmogenic right ventricular (RV) cardiomyopathy (RV dysplasia).

  • Unclassified cardiomyopathy: diseases that do not have features of 1 to 4 and include fibroelastosis and mitochondrial disease.

  • Specific cardiomyopathies (specific heart muscle diseases formerly termed secondary cardiomyopathy).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Ackerman MJ, McKenna WJ, Thierfelder L, et al. mutations in the genes for cardiac troponins T an alpha tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058–1064.

    Article  Google Scholar 

  2. Andersson B, Hamm C, Persson S, et al. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol 1994;23:1397.

    PubMed  CAS  Google Scholar 

  3. AVID: The Antiarrhythmic Versus Implantable Defibrillators Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576–1583.

    Article  Google Scholar 

  4. Boriani G, Maron BJ, Shen Win-Kuang, et al. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation 2004;110:e438–e442.

    Article  PubMed  Google Scholar 

  5. Bowles NE, Richardson PJ, Olsen EGJ, et al. Detection of Coxsackie-B virus specific RNA sequence in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;1:1120.

    Article  PubMed  CAS  Google Scholar 

  6. Braunwald E, Seidman CE, Sigwart U. Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation 2002;106:1312–1316.

    Article  PubMed  Google Scholar 

  7. CAPRICORN Investigators. The effect of carvedilol on outcome after myocardial infarcion in patients with left ventricular dysfunciton. The CAPRICORN randomized trial. Lancet 2001:357:1385–1390.

    Article  Google Scholar 

  8. Cice G, Ferrara L, Benedetto AD, et al. dilated cardiomyopathy in dialysis patients beneficial effects of carvedilol double-blind, placebo-controlled trial. J Am Coll Cardiol 2001;57:47–111.

    Google Scholar 

  9. COPERNICUS: carvedilol prospective randomized cumulative survival study group effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651–1658.

    Google Scholar 

  10. Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996;27:443.

    Article  PubMed  CAS  Google Scholar 

  11. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003;42:1959–1963.

    Article  PubMed  Google Scholar 

  12. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564.

    Article  PubMed  CAS  Google Scholar 

  13. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 1992;9:43.

    Article  Google Scholar 

  14. Elliott PM, Blanes G, Mahon JR, et al. A relation between the severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy bands at 2001;357:420–424.

    CAS  Google Scholar 

  15. EPHESUS: Pitt B, Remme W, Zannad F, et al., Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarcion. N Engl J Med 2003;348:1309–1321.

    Article  PubMed  CAS  Google Scholar 

  16. Eriksson MJ, Sonnenberg B, Woo A, et al. long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:638–645.

    Article  PubMed  Google Scholar 

  17. Fananapazir L, O’Connor RO, Tripodi D, et al. Impact of dual chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992;85:2149.

    PubMed  CAS  Google Scholar 

  18. Goodwin JF, Olsen EGJ (eds). Cardiomyopathies: realizations and expectations. Berlin: Springer Verlag, 1993.

    Google Scholar 

  19. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. J Am Coll Cardiol 1990;66:203.

    CAS  Google Scholar 

  20. Hejtmancik JF, Brink PA, Towbin J, et al. Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14ql in a diverse US population. Circulation 1991;83:1592.

    PubMed  CAS  Google Scholar 

  21. Hess OM, Sigwart U. New treatment strategies for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2004;44:2054–2055.

    Article  PubMed  Google Scholar 

  22. Kappenberger L. Pacing for obstructive hypertrophic cardiomyopathy. Br Heart J 1995;73:107.

    Article  PubMed  CAS  Google Scholar 

  23. Kasper EK, Agema WRP, Hutchings GM, et al. The causes of dilated cardiomyopathy: a clinicopatholigic review of 673 consecutive patients. J Am Coll Cardiol 1994;23:586.

    PubMed  CAS  Google Scholar 

  24. Leung WH, Lau CP, Wong CK, et al. Improvement in exercise performance and hemodynamic by labetalol in patients with idiopathic dilated cardiomyopathy. Am Heart J 1990;119:884.

    Article  PubMed  CAS  Google Scholar 

  25. Lowes BD, Gilbert EM, Abraham WT, et al. myocardial gene expression in dilated cardiomyopathy treated with beta blocking agents. N Engl J Med 2002;346:1357–1365.

    Article  PubMed  CAS  Google Scholar 

  26. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308–1320.

    Article  PubMed  Google Scholar 

  27. Maron BJ, Estes NA 3rd, Maron MS, Almquist AK, Link MS, Udelson JE. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 2003;107:2872–2875.

    Article  PubMed  Google Scholar 

  28. Maron B J, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CAR-DIA Study. Circulation 1995;92:785.

    PubMed  CAS  Google Scholar 

  29. Maron BJ, Dearani JA, Ommen SR, et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:2044–2053.

    Article  PubMed  Google Scholar 

  30. Maron B J, Seidman JG, Seidman CE. Proposal for contempory screenings strategies in families with hyper-trophic cardiomyopathy. J Am Coll Cardio. 2004;44:2125–2132.

    Article  Google Scholar 

  31. McKenna WJ, Mogensen J, Elliott PM. Role of genotype in risk factor assessment for sudden death in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:249–251.

    Article  Google Scholar 

  32. Nishimura RA, Hayes DL, Ilstrup DM, et al. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler Echocardiographic and Catheterization Hemodynamic Study. J Am Coll Cardiol 1996;27:421.

    Article  PubMed  CAS  Google Scholar 

  33. Nishimura RA, Holmes DR. Hypertrophic obstructive cardiomyopathy. N Eng J Med 2004;350:1320–1327.

    Article  CAS  Google Scholar 

  34. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349.

    Article  PubMed  CAS  Google Scholar 

  35. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Circulation 2002;106:2194–2187.

    Article  PubMed  Google Scholar 

  36. Roberts R, Sigwart U. New concepts in hypertrophic cardiomyopathies, part II. Circulation 2001;104:2249–2252.

    Article  PubMed  CAS  Google Scholar 

  37. Ryan MP, Cleland JFG, French J A, et al. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 1995;76:689.

    Article  PubMed  CAS  Google Scholar 

  38. Shamim W, Yousufuddin M, Wang D, et al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002;347:1326–1333.

    Article  PubMed  Google Scholar 

  39. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211.

    Article  PubMed  CAS  Google Scholar 

  40. Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:1778–1785.

    Article  PubMed  CAS  Google Scholar 

  41. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058.

    Article  PubMed  CAS  Google Scholar 

  42. Webb JG, Sasson Z, Rakowski H, et al. Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990;15:83.

    PubMed  CAS  Google Scholar 

  43. Wigle ED, Rakowski H, Kimball BP, et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995;92:1680.

    PubMed  CAS  Google Scholar 

  44. Williams RG, Chen AY. Identifying athletes at risk for sudden death. J Am Coll Cardiol 2003;42:1964–1966.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

(2005). Cardiomyopathy. In: Heart Disease Diagnosis and Therapy. Contemporary Cardiology. Humana Press. https://doi.org/10.1385/1-59259-868-4:443

Download citation

  • DOI: https://doi.org/10.1385/1-59259-868-4:443

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-439-5

  • Online ISBN: 978-1-59259-868-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation